Novavax filed for emergency use for its COVID-19 vaccine with the FDA Jan. 31. Two months later, there is still no sign of a decision from regulators.
Novavax filed for emergency use for its COVID-19 vaccine with the FDA Jan. 31. Two months later, there is still no sign of a decision from regulators.